LSE · GNOG.L
Global X - Genomics & Biotechnology UCITS ETF
£9.27-£0.37 (-3.86%)
Global X - Genomics & Biotechnology UCITS ETF’s quoted price sits in the upper half of its reported 52-week range, 7.45% below the high.
Loading market information…
LSE · GSEM.L · USD
Stock price
Quote as of Mar 23, 2026, 09:20 AM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Goldman Sachs ActiveBeta Emerging Markets Equity UCITS ETF’s quoted price sits in the upper half of its reported 52-week range, 11.57% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
This passively managed ETF aims for long-term capital appreciation by closely tracking, before any deductions for fees or expenses, the performance of the Goldman Sachs ActiveBeta Emerging Markets Equity Index Net Total Return. To achieve this objective, the fund replicates the index by investing in all its constituent securities, maintaining their respective weightings. These investments consist of shares in companies either headquartered in or deriving the majority of their income from emerging markets. It's important to note that any presented portfolio holdings or allocations are reflective of a specific date and may not be indicative of future investments, nor do they necessarily represent the complete portfolio. Future investments carry no guarantee of profitability, and there is no assurance that the fund's goals will be met.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Nov 2, 2026, 04:31 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
£9.27-£0.37 (-3.86%)
Global X - Genomics & Biotechnology UCITS ETF’s quoted price sits in the upper half of its reported 52-week range, 7.45% below the high.
$17.79-$0.96 (-5.12%)
KraneShares ICBCUBS SSE Star Market 50 Index UCITS ETF’s quoted price sits in the lower half of its reported 52-week range, 47.99% below the high.
$19.05+$0.08 (+0.44%)
HSBC MSCI Japan Climate Paris Aligned UCITS ETF’s quoted price sits in the upper half of its reported 52-week range, 3.89% below the high.
$28.41-$0.48 (-1.65%)
WisdomTree New Economy Real Estate UCITS ETF - USD Acc’s quoted price sits in the lower half of its reported 52-week range, 18.73% below the high.
$2.82-$0.08 (-2.6%)
Income Shares - Nasdaq 100 Options ETP’s quoted price sits in the lower half of its reported 52-week range, 38.94% below the high.
$150.70-$4.60 (-2.96%)
Leverage Shares - 2x Alphabet’s quoted price sits in the lower half of its reported 52-week range, 56.01% below the high.
$2.86+$0.02 (+0.58%)
WisdomTree Coffee 2x Daily Leveraged’s quoted price sits in the lower half of its reported 52-week range, 42.83% below the high.
£12.39-£0.10 (-0.82%)
First Trust Dow Jones International Internet UCITS ETF’s quoted price sits in the lower half of its reported 52-week range, 36.19% below the high.
